ResMed Inc. (ASX:RMD)
Australia
· Delayed Price · Currency is AUD | Market Cap | 51.43B |
| Revenue (ttm) | 7.96B |
| Net Income (ttm) | 2.02B |
| Shares Out | n/a |
| EPS (ttm) | 13.69 |
| PE Ratio | 25.49 |
| Forward PE | n/a |
| Dividend | 0.47 (1.33%) |
| Ex-Dividend Date | Feb 12, 2025 |
| Volume | 1,534,271 |
| Average Volume | 1,488,604 |
| Open | 35.22 |
| Previous Close | 35.39 |
| Day's Range | 35.08 - 35.40 |
| 52-Week Range | 27.05 - 40.75 |
| Beta | 0.74 |
| RSI | 42.69 |
| Earnings Date | Apr 25, 2025 |
About ResMed
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on de... [Read more]
Financial Performance
In 2024, ResMed's revenue was $4.69 billion, an increase of 10.95% compared to the previous year's $4.22 billion. Earnings were $1.02 billion, an increase of 13.75%.
Financial numbers in USD Financial StatementsNews
Lightning Round: Stay away from aluminum, says Jim Cramer
'Mad Money' host Jim Cramer weighs in on stocks including: Resmed, Twilio, NiSource, Reddit, and Google.
New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer
SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the publ...
Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution
SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a compreh...
ResMed Among Top Stocks For Recent And Long-Term Profit Growth
A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue?
Insider Sell Alert: Peter Farrell Sells 2,000 Shares of ResMed Inc (RMD)
Insider Sell Alert: Peter Farrell Sells 2,000 Shares of ResMed Inc (RMD)
My Top 15 High-Growth Dividend Stocks For March 2025
The SPDR S&P 500 ETF Trust stumbled in February but managed to maintain a positive return in 2025. The Top 15 dividend growth stocks for March 2025 offer an average dividend yield of 1.13% and appear ...
Here's How Much $1000 Invested In ResMed 10 Years Ago Would Be Worth Today
ResMed (NYSE: RMD) has outperformed the market over the past 10 years by 2.93% on an annualized basis producing an average annual return of 13.86%. Currently, ResMed has a market capitalization of $3...
ResMed Inc (RMD) Unveils Global Sleep Survey Highlighting Widespread Sleep Issues
ResMed Inc (RMD) Unveils Global Sleep Survey Highlighting Widespread Sleep Issues
ResMed's Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep
New insights from 30,026 people across 13 markets show the global scale of poor sleep and its impact on health, work, and relationships New insights from 30,026 people across 13 markets show the globa...
Insider Sell: Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD)
Insider Sell: Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD)
SECURE Act 2.0: What Every Retiree Needs to Know About RMD Changes
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. SECURE 2.0 has significant changes that could help streng...
Jan De Witte joins GHO Capital as Operating Partner
Jan De Witte joins GHO Capital as Operating Partner Former CEO of Integra LifeSciences with significant strategic and operational experience to support GHO Capital's portfolio London, UK – 11 February...
ResMed Close To Joining Very Elite Stock Group
ResMed shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
Revisiting ResMed In 2025: Strong Q2 Financial Results And The Growing Demand For Sleep Apnea Solutions
Stock Of The Day: Different Ways To Profit From SoundHound
Shares of SoundHound AI, Inc. (NASDAQ: SOUN) are making a nice move higher Tuesday. Some analysts believe that this is due to a report that suggests institutions make up more than 30% of the company'...
Stock Of The Day: Trading The Range In ResMed
ResMed Inc. (NYSE: RMD) shares are consolidating on Monday. This follows Friday's decline of more than 8%. The sell-off was driven by a disappointing earnings report . Traders are waiting to see if R...
Stock Of The Day: Trading The Range In ResMed
ResMed Inc. RMD shares are consolidating on Monday. This follows Friday's decline of more than 8%.
ResMed: Snoozers Can Be Winners
ResMed’s competitive edge is strong, but its current valuation seems inflated. Read why RMD stock might be ripe for profit-taking despite long-term growth.
ResMed Inc (RMD) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
ResMed Inc (RMD) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments Propel Performance
ResMed targets 59-60% gross margins and expanded global reach for AirSense 11
ResMed Inc. (RMD) Q2 2025 Earnings Call Transcript
ResMed: Digital Health Drives Q2 Growth
ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth in revenue and profitability.
ResMed beats earnings forecasts on sleep device demand
The US-based Australian sleep apnoea device giant has exceeded expectations with strong second quarter numbers.
Sleep device giant ResMed says Trump tariffs will boost profits
The US-based Australian sleep apnoea device giant has exceeded expectations with strong second quarter numbers.
Resmed declares fiscal Q2 dividend of $0.53
ResMed's (RMD) board of directors declared an unchanged quarterly dividend of $0.53 per share on Thursday. Read more here.